REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

医学蛛网膜下腔出血随机对照试验缺血麻醉脑缺血临床试验外科内科学

作者

Stephan A. Mayer,Nicolas Bruder,Giuseppe Citerio,Luc Defreyne,Cécile Dubois,Rajiv Gupta,Randall T. Higashida,Angelina Marr,Thanh N. Nguyen,Sébastiên Roux,Martin Smrčka,Ramón Torné,E. François Aldrich,NULL AUTHOR_ID,Claudius Thomé,Andreas Gruber,Xavier Wittebole,Luc Defreyne,Jacques Créteur,J. van Loon,Didier Ledoux,Tim E. Darsaut,Michael Kelly,Gwynedd E. Pickett,Anthony M. Kaufmann,Ondřej Bradáč,Martin Smrčka,S Rehák,Tomáš Hrbáč,Martin Sameš,Vladimír Přibáň,Troels Halfeld Nielsen,Peter Birkeland,Antti Ronkainen,Justiina Huhtakangas,Jaakko Rinne,Timo Koivisto,J.C. Dumont,Pierre Simeone,Russell Chabanne,Anne‐Claire Lukaszewicz,Thomas Ritzenthaler,Vincent Degos,Vincent Costalat,Philippe Séguin,Vincent Legros,Lionel Calviere,Étienne Gayat,Bertrand Rozec,Manfred Westphal,Sylvia Bele,Andreas Unterberg,Maria Wostrack,Sebastian Brandner,Ilker Y. Eyüpoglu,Juergen Konczalla,Nils Hecht,Stefan Wolf,Philipp Dammann,Ansgar Berlis,Angelika Ehlert,Jan Leppert,Ralph König,Jan F. Cornelius,A. Petridis,Florian Geßler,Attila Lajgut,Pál Barzó,András Büki,Péter Tóth,S. Szabó,Yigal Shoshann,Leon Levi,Moshe Attia,Sagi Harnof,Marina Munari,Giuseppe Citerio,Sandra Rossi,Anselmo Caricato,Paweł Słoniewski,Przemysław Kunert,Maciej Śniegocki,Dariusz J. Jaskólski,Robert Juszkat,J. Ibáñez,Alfonso Lagares,J.F. Alén,Fuat Arikan Abello,Andreu Gabarrós Canals,Ramón Torné,Jesús Morera Molina,Carlos Dominguez Alonso,Fabián Romero-Chala,Ola Nilsson,Johan Ljungqvist,Oscar Åneman,Johanna Eneling,Ajith J. Thomas,Christopher S. Ogilvy,Jesse Liu,Henry H. Woo,Nicholas C. Bambakidis,John Reavey‐Cantwell,Jan Claassen,Gary Steinberg,Eric Sauvageau,Ahmed Cheema,Bappaditya Ray,Jean Rodrigo Garcia,Masoom Desai,Thanh Nguyen,Ali Alaraj,Sepideh Amin‐Hanjani,Kadir Erkmen,Gregory J. Zipfel,Ciarán J. Powers,Hazem Shoirah,J Mocco,Paul Singh,François Aldrich,J. Marc Simard,Michael T. Froehler,Kevin M. Cockroft,William R. Freeman,Jia Romit

出处

期刊：Journal of Neurosurgery [American Association of Neurological Surgeons]
日期：2024-08-01 卷期号：: 1-12 被引量：2

链接

nih.govdoi.org

标识

DOI：10.3171/2024.4.jns232191

摘要

Ischemic complications account for significant patient morbidity following aneurysmal subarachnoid hemorrhage (aSAH). The Prevention and Treatment of Vasospasm with Clazosentan (REACT) study was designed to assess the safety and efficacy of clazosentan, an endothelin receptor antagonist, in preventing clinical deterioration due to delayed cerebral ischemia (DCI) in patients with aSAH.

求助该文献

最长约 10秒，即可获得该文献文件

REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

今日热心研友